Drug Type Unknown |
Synonyms SLV-154 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Endometrial Carcinoma | Phase 1 | United States | 14 May 2025 | |
| Metastatic breast cancer | Phase 1 | United States | 14 May 2025 | |
| Metastatic Carcinoma to the Uterine Cervix | Phase 1 | United States | 14 May 2025 | |
| Metastatic Solid Tumor | Phase 1 | United States | 14 May 2025 | |
| Non-Small Cell Lung Cancer | Phase 1 | United States | 14 May 2025 | |
| Ovarian Cancer | Phase 1 | United States | 14 May 2025 | |
| Sarcoma | Phase 1 | United States | 14 May 2025 | |
| Small Cell Lung Cancer | Phase 1 | United States | 14 May 2025 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 1 | United States | 14 May 2025 | |
| Thyroid Cancer | Phase 1 | United States | 14 May 2025 |





